Gene Symbol | Gene ID | Gene Info |
---|---|---|
ZNF333
|
ENSG00000160961.7 | zinc finger protein 333 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr19_14801365_14801665 | ZNF333 | 602 | 0.448905 | 0.69 | 3.9e-02 | Click! |
chr19_14793907_14794058 | ZNF333 | 6729 | 0.148288 | 0.50 | 1.7e-01 | Click! |
chr19_14799504_14799655 | ZNF333 | 1132 | 0.331585 | 0.33 | 3.8e-01 | Click! |
chr19_14801974_14802202 | ZNF333 | 1175 | 0.317608 | 0.33 | 3.8e-01 | Click! |
chr19_14800163_14800349 | ZNF333 | 455 | 0.525512 | 0.22 | 5.6e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr5_126324314_126324542 | 1.81 |
MARCH3 |
membrane-associated ring finger (C3HC4) 3, E3 ubiquitin protein ligase |
42072 |
0.18 |
chr1_67636156_67636590 | 1.67 |
IL23R |
interleukin 23 receptor |
4204 |
0.2 |
chrY_1731945_1732112 | 1.67 |
ENSG00000251841 |
. |
920762 |
0.0 |
chrX_1781946_1782112 | 1.67 |
ASMT |
acetylserotonin O-methyltransferase |
26738 |
0.22 |
chr12_68530648_68530810 | 1.66 |
IFNG |
interferon, gamma |
22798 |
0.24 |
chr3_178793021_178793370 | 1.65 |
ZMAT3 |
zinc finger, matrin-type 3 |
3128 |
0.27 |
chr19_10254159_10254310 | 1.48 |
EIF3G |
eukaryotic translation initiation factor 3, subunit G |
23656 |
0.07 |
chr17_76753532_76753758 | 1.45 |
CYTH1 |
cytohesin 1 |
20673 |
0.17 |
chr11_60841402_60841553 | 1.45 |
CD5 |
CD5 molecule |
28390 |
0.14 |
chr17_47823245_47823396 | 1.43 |
FAM117A |
family with sequence similarity 117, member A |
18173 |
0.14 |
chr5_130587781_130588081 | 1.43 |
CDC42SE2 |
CDC42 small effector 2 |
11771 |
0.27 |
chr10_14610710_14611033 | 1.42 |
FAM107B |
family with sequence similarity 107, member B |
3158 |
0.32 |
chr1_206739773_206740061 | 1.41 |
RASSF5 |
Ras association (RalGDS/AF-6) domain family member 5 |
9424 |
0.16 |
chr12_56331062_56331219 | 1.37 |
DGKA |
diacylglycerol kinase, alpha 80kDa |
1522 |
0.21 |
chr1_198663697_198663875 | 1.33 |
RP11-553K8.5 |
|
27596 |
0.22 |
chr14_92300266_92300422 | 1.29 |
TC2N |
tandem C2 domains, nuclear |
2440 |
0.31 |
chr2_99274253_99274492 | 1.25 |
MGAT4A |
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme A |
5564 |
0.23 |
chr17_72776501_72777115 | 1.24 |
TMEM104 |
transmembrane protein 104 |
4149 |
0.12 |
chr11_75063724_75064255 | 1.24 |
ARRB1 |
arrestin, beta 1 |
1116 |
0.42 |
chr12_9177186_9177502 | 1.24 |
RP11-259O18.4 |
|
28182 |
0.13 |
chr10_11260130_11260281 | 1.23 |
RP3-323N1.2 |
|
46866 |
0.15 |
chr14_61802522_61802673 | 1.21 |
PRKCH |
protein kinase C, eta |
8363 |
0.2 |
chr10_73868383_73868571 | 1.20 |
SPOCK2 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 |
19687 |
0.19 |
chr1_175266184_175266429 | 1.20 |
RP3-518E13.2 |
|
10048 |
0.28 |
chr2_44464820_44465026 | 1.17 |
ENSG00000239052 |
. |
1877 |
0.34 |
chr7_150374566_150375043 | 1.17 |
GIMAP2 |
GTPase, IMAP family member 2 |
7984 |
0.18 |
chr1_193430027_193430686 | 1.16 |
ENSG00000252241 |
. |
270718 |
0.01 |
chr22_39542643_39542972 | 1.16 |
CBX7 |
chromobox homolog 7 |
5642 |
0.17 |
chr6_45980700_45980851 | 1.14 |
CLIC5 |
chloride intracellular channel 5 |
2790 |
0.3 |
chr5_109193839_109194454 | 1.13 |
AC011366.3 |
Uncharacterized protein |
24737 |
0.26 |
chr22_40312539_40312695 | 1.13 |
GRAP2 |
GRB2-related adaptor protein 2 |
9978 |
0.17 |
chr9_123665931_123666216 | 1.13 |
TRAF1 |
TNF receptor-associated factor 1 |
10777 |
0.19 |
chr18_68366154_68366305 | 1.12 |
GTSCR1 |
Gilles de la Tourette syndrome chromosome region, candidate 1 |
48249 |
0.2 |
chr7_38312227_38312378 | 1.12 |
STARD3NL |
STARD3 N-terminal like |
94305 |
0.09 |
chr1_100824495_100824731 | 1.11 |
CDC14A |
cell division cycle 14A |
6108 |
0.2 |
chr2_202134110_202134598 | 1.11 |
CASP8 |
caspase 8, apoptosis-related cysteine peptidase |
3007 |
0.26 |
chr2_242219929_242220080 | 1.11 |
HDLBP |
high density lipoprotein binding protein |
7472 |
0.15 |
chr17_46497392_46497543 | 1.11 |
SKAP1 |
src kinase associated phosphoprotein 1 |
10085 |
0.14 |
chr4_39028874_39029217 | 1.10 |
TMEM156 |
transmembrane protein 156 |
4996 |
0.23 |
chr3_67789239_67789462 | 1.09 |
SUCLG2 |
succinate-CoA ligase, GDP-forming, beta subunit |
84312 |
0.1 |
chr6_109381834_109382031 | 1.08 |
ENSG00000199944 |
. |
1115 |
0.52 |
chr6_41694624_41694991 | 1.08 |
TFEB |
transcription factor EB |
3343 |
0.15 |
chr6_44898953_44899135 | 1.07 |
SUPT3H |
suppressor of Ty 3 homolog (S. cerevisiae) |
24203 |
0.27 |
chr9_71633765_71634208 | 1.07 |
PRKACG |
protein kinase, cAMP-dependent, catalytic, gamma |
4947 |
0.24 |
chr1_101577270_101577506 | 1.07 |
ENSG00000252765 |
. |
21321 |
0.18 |
chr18_68330921_68331227 | 1.07 |
GTSCR1 |
Gilles de la Tourette syndrome chromosome region, candidate 1 |
13094 |
0.31 |
chr2_158271446_158271770 | 1.06 |
CYTIP |
cytohesin 1 interacting protein |
24318 |
0.19 |
chr1_42271230_42271400 | 1.06 |
ENSG00000264896 |
. |
46503 |
0.18 |
chr21_36305039_36305387 | 1.05 |
RUNX1 |
runt-related transcription factor 1 |
43126 |
0.21 |
chr3_107795044_107795195 | 1.05 |
CD47 |
CD47 molecule |
14742 |
0.29 |
chr3_71387446_71387597 | 1.05 |
FOXP1 |
forkhead box P1 |
33610 |
0.2 |
chr20_37432775_37433181 | 1.04 |
PPP1R16B |
protein phosphatase 1, regulatory subunit 16B |
1370 |
0.43 |
chr3_68139067_68139395 | 1.04 |
FAM19A1 |
family with sequence similarity 19 (chemokine (C-C motif)-like), member A1 |
83858 |
0.11 |
chr6_143867691_143867928 | 1.04 |
PHACTR2 |
phosphatase and actin regulator 2 |
9827 |
0.16 |
chr1_167482789_167483038 | 1.04 |
CD247 |
CD247 molecule |
4862 |
0.23 |
chr9_123951737_123951888 | 1.04 |
RAB14 |
RAB14, member RAS oncogene family |
12335 |
0.15 |
chr6_119130312_119130507 | 1.03 |
MCM9 |
minichromosome maintenance complex component 9 |
20007 |
0.24 |
chr5_55987934_55988290 | 1.02 |
AC022431.2 |
Homo sapiens uncharacterized LOC101928448 (LOC101928448), mRNA. |
86053 |
0.08 |
chr1_84631383_84631693 | 1.02 |
PRKACB |
protein kinase, cAMP-dependent, catalytic, beta |
889 |
0.71 |
chr20_57753276_57753706 | 1.02 |
ZNF831 |
zinc finger protein 831 |
12584 |
0.25 |
chr2_208407990_208408141 | 1.01 |
CREB1 |
cAMP responsive element binding protein 1 |
6920 |
0.21 |
chr8_82006436_82006760 | 1.01 |
PAG1 |
phosphoprotein associated with glycosphingolipid microdomains 1 |
17705 |
0.27 |
chr6_11715352_11715573 | 0.99 |
ENSG00000207419 |
. |
5410 |
0.27 |
chr2_158287829_158287980 | 0.99 |
CYTIP |
cytohesin 1 interacting protein |
8022 |
0.23 |
chr22_45570848_45571064 | 0.99 |
CTA-268H5.12 |
|
3915 |
0.19 |
chr6_130451744_130451895 | 0.99 |
RP11-73O6.3 |
|
7522 |
0.25 |
chr15_60830873_60831064 | 0.98 |
CTD-2501E16.2 |
|
8796 |
0.2 |
chr3_33060833_33061054 | 0.98 |
CCR4 |
chemokine (C-C motif) receptor 4 |
67877 |
0.09 |
chr14_106963793_106964019 | 0.98 |
IGHV1-45 |
immunoglobulin heavy variable 1-45 |
482 |
0.45 |
chr11_108087287_108087517 | 0.97 |
ATM |
ataxia telangiectasia mutated |
5809 |
0.17 |
chr14_69462402_69462553 | 0.97 |
ACTN1-AS1 |
ACTN1 antisense RNA 1 |
15719 |
0.21 |
chr22_30743283_30743633 | 0.96 |
SF3A1 |
splicing factor 3a, subunit 1, 120kDa |
5619 |
0.1 |
chr12_92772495_92772646 | 0.95 |
RP11-693J15.4 |
|
42737 |
0.14 |
chr1_110048089_110048334 | 0.95 |
AMIGO1 |
adhesion molecule with Ig-like domain 1 |
4093 |
0.12 |
chr1_101586595_101586746 | 0.95 |
ENSG00000252765 |
. |
12039 |
0.2 |
chr11_118087201_118087579 | 0.95 |
AMICA1 |
adhesion molecule, interacts with CXADR antigen 1 |
1784 |
0.28 |
chr2_175359311_175359644 | 0.94 |
GPR155 |
G protein-coupled receptor 155 |
7655 |
0.2 |
chr17_4042379_4042690 | 0.94 |
ZZEF1 |
zinc finger, ZZ-type with EF-hand domain 1 |
3780 |
0.15 |
chr13_108979091_108979372 | 0.94 |
ENSG00000223177 |
. |
25552 |
0.22 |
chr6_24938751_24938902 | 0.94 |
FAM65B |
family with sequence similarity 65, member B |
2638 |
0.33 |
chr1_101395582_101395733 | 0.94 |
SLC30A7 |
solute carrier family 30 (zinc transporter), member 7 |
31727 |
0.12 |
chr18_13380419_13380663 | 0.94 |
LDLRAD4 |
low density lipoprotein receptor class A domain containing 4 |
2012 |
0.28 |
chr2_32036582_32036828 | 0.93 |
ENSG00000238448 |
. |
1348 |
0.49 |
chr20_47394311_47394486 | 0.93 |
ENSG00000251876 |
. |
38413 |
0.18 |
chr11_9416407_9416558 | 0.93 |
IPO7 |
importin 7 |
10282 |
0.16 |
chr14_23031750_23031930 | 0.93 |
AE000662.93 |
|
5884 |
0.11 |
chr20_1639703_1639854 | 0.93 |
SIRPG |
signal-regulatory protein gamma |
1353 |
0.36 |
chr12_120450626_120450780 | 0.93 |
CCDC64 |
coiled-coil domain containing 64 |
23030 |
0.17 |
chr2_143943022_143943284 | 0.93 |
RP11-190J23.1 |
|
13412 |
0.27 |
chr21_43843966_43844673 | 0.92 |
ENSG00000252619 |
. |
6617 |
0.14 |
chr21_43819209_43819401 | 0.92 |
TMPRSS3 |
transmembrane protease, serine 3 |
2350 |
0.2 |
chr2_183901743_183901960 | 0.92 |
NCKAP1 |
NCK-associated protein 1 |
1349 |
0.4 |
chr6_131688561_131688712 | 0.92 |
AKAP7 |
A kinase (PRKA) anchor protein 7 |
117066 |
0.06 |
chr6_143158082_143158317 | 0.92 |
HIVEP2 |
human immunodeficiency virus type I enhancer binding protein 2 |
15 |
0.99 |
chr11_13881982_13882161 | 0.92 |
ENSG00000201856 |
. |
47066 |
0.18 |
chr3_66352404_66352729 | 0.92 |
ENSG00000206759 |
. |
8922 |
0.23 |
chr10_90584146_90584402 | 0.92 |
LIPM |
lipase, family member M |
21569 |
0.15 |
chr7_144508892_144509461 | 0.92 |
TPK1 |
thiamin pyrophosphokinase 1 |
23970 |
0.23 |
chr15_38957763_38957914 | 0.92 |
C15orf53 |
chromosome 15 open reading frame 53 |
30961 |
0.22 |
chr17_28067929_28068080 | 0.91 |
RP11-82O19.1 |
|
20117 |
0.14 |
chr1_25350610_25350934 | 0.91 |
ENSG00000264371 |
. |
778 |
0.7 |
chr2_136809392_136809630 | 0.91 |
AC093391.2 |
|
39476 |
0.17 |
chr10_75528435_75528586 | 0.91 |
FUT11 |
fucosyltransferase 11 (alpha (1,3) fucosyltransferase) |
3539 |
0.09 |
chr3_31585090_31585298 | 0.91 |
STT3B |
STT3B, subunit of the oligosaccharyltransferase complex (catalytic) |
10912 |
0.3 |
chr15_64804332_64804483 | 0.90 |
ZNF609 |
zinc finger protein 609 |
12916 |
0.16 |
chr1_111209754_111210001 | 0.90 |
KCNA3 |
potassium voltage-gated channel, shaker-related subfamily, member 3 |
7778 |
0.18 |
chr11_14656520_14656824 | 0.90 |
PSMA1 |
proteasome (prosome, macropain) subunit, alpha type, 1 |
8491 |
0.23 |
chr10_102703360_102703526 | 0.90 |
SEMA4G |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4G |
25832 |
0.09 |
chr3_136639103_136639532 | 0.89 |
NCK1 |
NCK adaptor protein 1 |
7564 |
0.2 |
chr13_77590528_77590679 | 0.89 |
FBXL3 |
F-box and leucine-rich repeat protein 3 |
10682 |
0.18 |
chr3_134013773_134013924 | 0.89 |
RYK |
receptor-like tyrosine kinase |
44159 |
0.16 |
chr6_24924284_24924680 | 0.89 |
FAM65B |
family with sequence similarity 65, member B |
11706 |
0.23 |
chr6_79751608_79751894 | 0.89 |
PHIP |
pleckstrin homology domain interacting protein |
36202 |
0.2 |
chr5_75844582_75844760 | 0.88 |
IQGAP2 |
IQ motif containing GTPase activating protein 2 |
1437 |
0.5 |
chr17_1198651_1199134 | 0.88 |
TUSC5 |
tumor suppressor candidate 5 |
15935 |
0.17 |
chr9_92081450_92081888 | 0.87 |
SEMA4D |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
10801 |
0.24 |
chr9_77742849_77743103 | 0.87 |
OSTF1 |
osteoclast stimulating factor 1 |
39517 |
0.13 |
chr5_67553238_67553759 | 0.87 |
PIK3R1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
17772 |
0.26 |
chr6_152507132_152507415 | 0.87 |
SYNE1 |
spectrin repeat containing, nuclear envelope 1 |
17774 |
0.28 |
chr1_239884284_239884571 | 0.87 |
CHRM3 |
cholinergic receptor, muscarinic 3 |
1584 |
0.4 |
chr13_20543344_20543510 | 0.87 |
ZMYM2 |
zinc finger, MYM-type 2 |
10504 |
0.21 |
chr9_282696_283160 | 0.87 |
DOCK8 |
dedicator of cytokinesis 8 |
9858 |
0.2 |
chr16_50388635_50388850 | 0.87 |
ENSG00000238544 |
. |
2539 |
0.25 |
chr13_41235126_41235413 | 0.87 |
FOXO1 |
forkhead box O1 |
5465 |
0.26 |
chr2_64011466_64011617 | 0.86 |
UGP2 |
UDP-glucose pyrophosphorylase 2 |
56533 |
0.14 |
chr8_82004605_82004756 | 0.86 |
PAG1 |
phosphoprotein associated with glycosphingolipid microdomains 1 |
19623 |
0.27 |
chr1_100890748_100890987 | 0.86 |
ENSG00000216067 |
. |
46536 |
0.13 |
chr3_46019508_46019702 | 0.86 |
FYCO1 |
FYVE and coiled-coil domain containing 1 |
6882 |
0.19 |
chr4_103431683_103431834 | 0.86 |
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
7226 |
0.22 |
chr6_159464056_159464207 | 0.86 |
TAGAP |
T-cell activation RhoGTPase activating protein |
1919 |
0.34 |
chr3_3215171_3215452 | 0.86 |
CRBN |
cereblon |
6047 |
0.2 |
chr18_29623121_29623509 | 0.86 |
ENSG00000265063 |
. |
17637 |
0.13 |
chr10_91094740_91095021 | 0.86 |
IFIT3 |
interferon-induced protein with tetratricopeptide repeats 3 |
2639 |
0.2 |
chr9_4409457_4409608 | 0.85 |
ENSG00000200941 |
. |
22976 |
0.19 |
chr8_29951541_29951775 | 0.85 |
LEPROTL1 |
leptin receptor overlapping transcript-like 1 |
1256 |
0.39 |
chr8_129693831_129694008 | 0.85 |
ENSG00000221351 |
. |
138121 |
0.05 |
chrX_44942775_44943113 | 0.85 |
KDM6A |
lysine (K)-specific demethylase 6A |
7118 |
0.3 |
chr10_6573467_6573756 | 0.85 |
PRKCQ |
protein kinase C, theta |
48590 |
0.18 |
chr1_32384187_32384338 | 0.85 |
PTP4A2 |
protein tyrosine phosphatase type IVA, member 2 |
448 |
0.81 |
chr15_52974342_52974495 | 0.85 |
FAM214A |
family with sequence similarity 214, member A |
2849 |
0.31 |
chr6_36507681_36507832 | 0.85 |
STK38 |
serine/threonine kinase 38 |
7491 |
0.15 |
chr4_37894193_37894870 | 0.84 |
TBC1D1 |
TBC1 (tre-2/USP6, BUB2, cdc16) domain family, member 1 |
1811 |
0.44 |
chr3_69113429_69113708 | 0.84 |
TMF1 |
TATA element modulatory factor 1 |
12084 |
0.13 |
chr17_75662489_75662681 | 0.84 |
SEPT9 |
septin 9 |
184590 |
0.03 |
chr6_11261291_11261442 | 0.84 |
NEDD9 |
neural precursor cell expressed, developmentally down-regulated 9 |
28451 |
0.21 |
chr21_43659423_43659598 | 0.84 |
ABCG1 |
ATP-binding cassette, sub-family G (WHITE), member 1 |
16684 |
0.16 |
chr14_65905383_65905557 | 0.83 |
FUT8 |
fucosyltransferase 8 (alpha (1,6) fucosyltransferase) |
25730 |
0.2 |
chr15_60851868_60852068 | 0.83 |
CTD-2501E16.2 |
|
29796 |
0.16 |
chr4_90165366_90165517 | 0.83 |
GPRIN3 |
GPRIN family member 3 |
6904 |
0.3 |
chr5_156607006_156607188 | 0.83 |
ITK |
IL2-inducible T-cell kinase |
740 |
0.56 |
chr2_48582727_48582954 | 0.83 |
ENSG00000251889 |
. |
14875 |
0.22 |
chr14_66394986_66395728 | 0.83 |
CTD-2014B16.3 |
Uncharacterized protein |
75884 |
0.11 |
chr5_110569357_110569585 | 0.83 |
CAMK4 |
calcium/calmodulin-dependent protein kinase IV |
9687 |
0.23 |
chr14_71458191_71458391 | 0.83 |
PCNX |
pecanex homolog (Drosophila) |
21457 |
0.27 |
chr13_100193349_100193645 | 0.83 |
ENSG00000212197 |
. |
4847 |
0.21 |
chr15_55576512_55576932 | 0.82 |
RAB27A |
RAB27A, member RAS oncogene family |
5279 |
0.21 |
chr8_48510635_48510787 | 0.82 |
SPIDR |
scaffolding protein involved in DNA repair |
61515 |
0.12 |
chr17_75842366_75842622 | 0.82 |
FLJ45079 |
|
36165 |
0.19 |
chr14_61862914_61863071 | 0.82 |
PRKCH |
protein kinase C, eta |
5580 |
0.27 |
chr9_88962805_88962956 | 0.82 |
ZCCHC6 |
zinc finger, CCHC domain containing 6 |
4741 |
0.27 |
chr11_62480758_62481047 | 0.82 |
BSCL2 |
Berardinelli-Seip congenital lipodystrophy 2 (seipin) |
3585 |
0.07 |
chr2_200470717_200470868 | 0.82 |
SATB2 |
SATB homeobox 2 |
134803 |
0.05 |
chr6_24842317_24842468 | 0.82 |
ENSG00000263391 |
. |
2099 |
0.3 |
chr2_197041376_197041796 | 0.81 |
STK17B |
serine/threonine kinase 17b |
359 |
0.88 |
chr17_62964316_62964742 | 0.81 |
AMZ2P1 |
archaelysin family metallopeptidase 2 pseudogene 1 |
5106 |
0.16 |
chrX_80471398_80471549 | 0.81 |
SH3BGRL |
SH3 domain binding glutamic acid-rich protein like |
14031 |
0.2 |
chr1_78506554_78506705 | 0.81 |
GIPC2 |
GIPC PDZ domain containing family, member 2 |
4957 |
0.18 |
chr5_61595161_61595407 | 0.81 |
KIF2A |
kinesin heavy chain member 2A |
6705 |
0.29 |
chr12_46274112_46274320 | 0.81 |
ENSG00000265093 |
. |
6404 |
0.25 |
chr10_22889756_22889967 | 0.81 |
PIP4K2A |
phosphatidylinositol-5-phosphate 4-kinase, type II, alpha |
9219 |
0.3 |
chr5_156778212_156778363 | 0.80 |
FNDC9 |
fibronectin type III domain containing 9 |
5558 |
0.17 |
chr3_40506460_40506611 | 0.80 |
RPL14 |
ribosomal protein L14 |
7690 |
0.15 |
chr10_22030183_22030447 | 0.80 |
ENSG00000252634 |
. |
43906 |
0.15 |
chr12_3983132_3983317 | 0.80 |
PARP11 |
poly (ADP-ribose) polymerase family, member 11 |
616 |
0.74 |
chr2_191934456_191934744 | 0.80 |
ENSG00000231858 |
. |
48348 |
0.11 |
chr1_175180542_175180693 | 0.80 |
KIAA0040 |
KIAA0040 |
18538 |
0.24 |
chr12_94425803_94426005 | 0.80 |
ENSG00000223126 |
. |
23081 |
0.22 |
chr2_25558269_25558542 | 0.80 |
DNMT3A |
DNA (cytosine-5-)-methyltransferase 3 alpha |
6349 |
0.22 |
chr3_43237083_43237612 | 0.80 |
ENSG00000222331 |
. |
15016 |
0.22 |
chr15_63765311_63765469 | 0.80 |
USP3 |
ubiquitin specific peptidase 3 |
31403 |
0.19 |
chr14_53209868_53210049 | 0.80 |
STYX |
serine/threonine/tyrosine interacting protein |
13058 |
0.15 |
chr18_21628942_21629093 | 0.80 |
TTC39C |
tetratricopeptide repeat domain 39C |
32419 |
0.12 |
chr2_198860203_198860402 | 0.80 |
PLCL1 |
phospholipase C-like 1 |
88234 |
0.1 |
chr18_47312188_47312542 | 0.79 |
ACAA2 |
acetyl-CoA acyltransferase 2 |
25536 |
0.13 |
chr8_126658824_126659129 | 0.79 |
ENSG00000266452 |
. |
202169 |
0.03 |
chr1_112140503_112140654 | 0.79 |
RAP1A |
RAP1A, member of RAS oncogene family |
21821 |
0.15 |
chr17_8862492_8862649 | 0.79 |
PIK3R5 |
phosphoinositide-3-kinase, regulatory subunit 5 |
6454 |
0.26 |
chr2_158301630_158301829 | 0.79 |
CYTIP |
cytohesin 1 interacting protein |
1075 |
0.56 |
chr4_40067184_40067335 | 0.79 |
N4BP2 |
NEDD4 binding protein 2 |
8703 |
0.17 |
chr20_17491810_17492073 | 0.79 |
BFSP1 |
beaded filament structural protein 1, filensin |
20073 |
0.21 |
chr21_19162869_19163124 | 0.79 |
AL109761.5 |
|
2809 |
0.31 |
chr17_63708928_63709079 | 0.79 |
CEP112 |
centrosomal protein 112kDa |
37839 |
0.22 |
chr17_46970506_46970752 | 0.79 |
ATP5G1 |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9) |
46 |
0.95 |
chr3_56814100_56814302 | 0.79 |
ARHGEF3 |
Rho guanine nucleotide exchange factor (GEF) 3 |
4516 |
0.32 |
chr2_12250541_12250951 | 0.79 |
ENSG00000238503 |
. |
80248 |
0.1 |
chr17_38023149_38023300 | 0.78 |
ZPBP2 |
zona pellucida binding protein 2 |
1193 |
0.37 |
chr6_41997739_41997992 | 0.78 |
ENSG00000206875 |
. |
11613 |
0.15 |
chr11_65199664_65199929 | 0.78 |
ENSG00000245532 |
. |
12133 |
0.11 |
chr2_86089332_86089543 | 0.78 |
ST3GAL5 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 5 |
5340 |
0.21 |
chr9_96232044_96232195 | 0.78 |
FAM120AOS |
family with sequence similarity 120A opposite strand |
16245 |
0.14 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 3.3 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
0.7 | 1.5 | GO:0002666 | T cell tolerance induction(GO:0002517) regulation of T cell tolerance induction(GO:0002664) positive regulation of T cell tolerance induction(GO:0002666) |
0.7 | 2.9 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.6 | 2.5 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.6 | 2.5 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.6 | 2.5 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.6 | 1.7 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.6 | 2.3 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.5 | 1.6 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.5 | 0.5 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.5 | 3.3 | GO:0007172 | signal complex assembly(GO:0007172) |
0.5 | 0.5 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.4 | 0.4 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.4 | 1.3 | GO:0046137 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
0.4 | 1.3 | GO:0045066 | regulatory T cell differentiation(GO:0045066) |
0.4 | 1.3 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.4 | 1.3 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.4 | 1.2 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.4 | 1.2 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.4 | 1.6 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.4 | 1.1 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.4 | 1.9 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.4 | 1.1 | GO:0043320 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
0.4 | 3.0 | GO:0002836 | regulation of response to tumor cell(GO:0002834) positive regulation of response to tumor cell(GO:0002836) regulation of immune response to tumor cell(GO:0002837) positive regulation of immune response to tumor cell(GO:0002839) |
0.4 | 1.8 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.4 | 0.7 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.4 | 1.1 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) positive regulation of protein acetylation(GO:1901985) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.4 | 3.2 | GO:0043368 | positive T cell selection(GO:0043368) |
0.3 | 2.8 | GO:0006491 | N-glycan processing(GO:0006491) |
0.3 | 1.7 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.3 | 1.0 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.3 | 0.7 | GO:0002713 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) |
0.3 | 0.6 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.3 | 0.6 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.3 | 1.5 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.3 | 0.9 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.3 | 2.3 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.3 | 17.0 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.3 | 1.3 | GO:1901797 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.3 | 1.1 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.3 | 1.1 | GO:0060287 | epithelial cilium movement(GO:0003351) epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.3 | 0.3 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.3 | 2.3 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.3 | 0.5 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.3 | 0.3 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.3 | 1.3 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.2 | 0.7 | GO:0032506 | cytokinetic process(GO:0032506) |
0.2 | 0.7 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.2 | 0.7 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.2 | 0.5 | GO:0002691 | regulation of cellular extravasation(GO:0002691) positive regulation of cellular extravasation(GO:0002693) |
0.2 | 0.7 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.2 | 0.2 | GO:0035872 | cytoplasmic pattern recognition receptor signaling pathway(GO:0002753) nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.2 | 1.1 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.2 | 1.4 | GO:0032733 | positive regulation of interleukin-10 production(GO:0032733) |
0.2 | 0.7 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.2 | 0.4 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.2 | 0.4 | GO:0052257 | pathogen-associated molecular pattern dependent induction by symbiont of host innate immune response(GO:0052033) positive regulation by symbiont of host innate immune response(GO:0052166) modulation by symbiont of host innate immune response(GO:0052167) pathogen-associated molecular pattern dependent modulation by symbiont of host innate immune response(GO:0052169) pathogen-associated molecular pattern dependent induction by organism of innate immune response of other organism involved in symbiotic interaction(GO:0052257) positive regulation by organism of innate immune response in other organism involved in symbiotic interaction(GO:0052305) modulation by organism of innate immune response in other organism involved in symbiotic interaction(GO:0052306) pathogen-associated molecular pattern dependent modulation by organism of innate immune response in other organism involved in symbiotic interaction(GO:0052308) |
0.2 | 0.7 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.2 | 0.6 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.2 | 1.5 | GO:0002063 | chondrocyte development(GO:0002063) |
0.2 | 0.8 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.2 | 0.2 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.2 | 2.1 | GO:0019059 | obsolete initiation of viral infection(GO:0019059) |
0.2 | 2.2 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.2 | 1.4 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.2 | 0.4 | GO:0019060 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) regulation by virus of viral protein levels in host cell(GO:0046719) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.2 | 0.4 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.2 | 0.2 | GO:0010713 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of multicellular organismal metabolic process(GO:0044252) |
0.2 | 0.6 | GO:0051182 | coenzyme transport(GO:0051182) |
0.2 | 1.3 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.2 | 0.4 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.2 | 0.8 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.2 | 0.6 | GO:0060088 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.2 | 0.6 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.2 | 0.6 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) |
0.2 | 0.2 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.2 | 0.6 | GO:0051459 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.2 | 0.6 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.2 | 0.6 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.2 | 2.8 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.2 | 0.2 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.2 | 0.5 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.2 | 1.3 | GO:0051294 | establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
0.2 | 0.2 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.2 | 0.7 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.2 | 0.9 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.2 | 2.2 | GO:0000303 | response to superoxide(GO:0000303) |
0.2 | 0.2 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.2 | 0.5 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.2 | 0.5 | GO:0001821 | histamine secretion(GO:0001821) |
0.2 | 0.5 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.2 | 1.0 | GO:0060123 | regulation of growth hormone secretion(GO:0060123) |
0.2 | 0.5 | GO:0046476 | glycosylceramide biosynthetic process(GO:0046476) |
0.2 | 0.7 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.2 | 0.2 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.2 | 0.7 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.2 | 0.5 | GO:1902745 | positive regulation of lamellipodium assembly(GO:0010592) positive regulation of lamellipodium organization(GO:1902745) |
0.2 | 0.5 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.2 | 0.7 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.2 | 0.3 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.2 | 0.3 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.2 | 0.3 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.2 | 0.7 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.2 | 0.5 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.2 | 0.5 | GO:0072600 | protein targeting to Golgi(GO:0000042) establishment of protein localization to Golgi(GO:0072600) |
0.2 | 0.8 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.2 | 0.6 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.2 | 0.2 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.2 | 0.3 | GO:0002507 | tolerance induction(GO:0002507) |
0.2 | 0.2 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.2 | 0.2 | GO:0071224 | cellular response to peptidoglycan(GO:0071224) |
0.2 | 0.5 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.1 | 0.4 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) glial cell fate specification(GO:0021780) |
0.1 | 0.3 | GO:1903038 | negative regulation of T cell activation(GO:0050868) negative regulation of leukocyte cell-cell adhesion(GO:1903038) |
0.1 | 0.4 | GO:0097300 | necroptotic process(GO:0070266) programmed necrotic cell death(GO:0097300) |
0.1 | 0.4 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 0.6 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.1 | 1.6 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.1 | 0.3 | GO:0033080 | immature T cell proliferation(GO:0033079) immature T cell proliferation in thymus(GO:0033080) regulation of immature T cell proliferation(GO:0033083) negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.1 | 0.3 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.1 | 2.1 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.1 | 0.3 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 1.4 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 0.3 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.1 | 0.7 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.1 | 1.1 | GO:0046348 | amino sugar catabolic process(GO:0046348) glucosamine-containing compound catabolic process(GO:1901072) |
0.1 | 0.5 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.1 | 2.1 | GO:0060334 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.1 | 0.4 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.4 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.1 | 0.4 | GO:0045056 | transcytosis(GO:0045056) |
0.1 | 0.1 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
0.1 | 0.3 | GO:0010834 | obsolete telomere maintenance via telomere shortening(GO:0010834) |
0.1 | 0.3 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.1 | 1.0 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.1 | 0.5 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.1 | 0.4 | GO:0001916 | positive regulation of T cell mediated cytotoxicity(GO:0001916) |
0.1 | 1.2 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.1 | 0.3 | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882) |
0.1 | 1.7 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.1 | 1.3 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.1 | 0.1 | GO:0002448 | mast cell mediated immunity(GO:0002448) |
0.1 | 0.5 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.4 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.1 | 0.4 | GO:0034626 | fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 0.7 | GO:1904031 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.1 | 0.1 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.1 | 1.0 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.1 | 0.5 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
0.1 | 0.4 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.1 | 0.5 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.1 | 0.4 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.1 | 0.4 | GO:0014889 | muscle atrophy(GO:0014889) |
0.1 | 0.6 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.2 | GO:0046101 | hypoxanthine biosynthetic process(GO:0046101) |
0.1 | 0.2 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.1 | 0.1 | GO:0060556 | regulation of vitamin metabolic process(GO:0030656) vitamin D biosynthetic process(GO:0042368) regulation of vitamin D biosynthetic process(GO:0060556) regulation of calcidiol 1-monooxygenase activity(GO:0060558) |
0.1 | 0.6 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.1 | 0.7 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.1 | 0.3 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.1 | 0.3 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.1 | 0.2 | GO:0061054 | dermatome development(GO:0061054) |
0.1 | 0.3 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.1 | 0.3 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 0.1 | GO:0031223 | auditory behavior(GO:0031223) |
0.1 | 0.2 | GO:0010536 | regulation of activation of Janus kinase activity(GO:0010533) positive regulation of activation of Janus kinase activity(GO:0010536) |
0.1 | 1.6 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.1 | 0.8 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.1 | 0.7 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.1 | 3.1 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.1 | 1.3 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.1 | 0.8 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 0.4 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.1 | 0.3 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.1 | 0.5 | GO:0002717 | positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.1 | 0.2 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.1 | 0.4 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.1 | 0.5 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 0.1 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.1 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.1 | 0.1 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.1 | 0.2 | GO:0034371 | chylomicron remodeling(GO:0034371) |
0.1 | 0.5 | GO:0048488 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.1 | 0.3 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 0.3 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.1 | 0.1 | GO:0060242 | contact inhibition(GO:0060242) |
0.1 | 0.1 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.1 | 0.1 | GO:0002886 | regulation of myeloid leukocyte mediated immunity(GO:0002886) |
0.1 | 0.2 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.1 | 0.5 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.1 | 0.1 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.1 | 2.1 | GO:0031294 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.1 | 1.6 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.1 | 0.1 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.1 | 0.1 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 0.7 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 0.3 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 0.3 | GO:1902101 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.1 | 0.3 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.4 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.5 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.1 | 0.1 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
0.1 | 0.4 | GO:0021604 | facial nerve development(GO:0021561) cranial nerve structural organization(GO:0021604) facial nerve morphogenesis(GO:0021610) facial nerve structural organization(GO:0021612) anatomical structure arrangement(GO:0048532) |
0.1 | 0.7 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.1 | 0.3 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.1 | 1.9 | GO:0044349 | nucleotide-excision repair, DNA damage removal(GO:0000718) DNA excision(GO:0044349) |
0.1 | 0.3 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.1 | 0.9 | GO:1901663 | quinone biosynthetic process(GO:1901663) |
0.1 | 0.8 | GO:0032456 | endocytic recycling(GO:0032456) |
0.1 | 0.2 | GO:0009296 | obsolete flagellum assembly(GO:0009296) |
0.1 | 0.5 | GO:0007440 | foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
0.1 | 0.3 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.6 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 1.3 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.1 | 0.3 | GO:0010761 | fibroblast migration(GO:0010761) |
0.1 | 0.2 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.1 | 0.2 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.1 | 0.2 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.1 | 0.1 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.1 | 0.2 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.1 | 0.4 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.1 | 0.2 | GO:2000644 | regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) regulation of receptor catabolic process(GO:2000644) |
0.1 | 0.4 | GO:0014741 | negative regulation of muscle hypertrophy(GO:0014741) |
0.1 | 0.3 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.3 | GO:0090205 | positive regulation of cholesterol metabolic process(GO:0090205) |
0.1 | 0.2 | GO:0002085 | inhibition of neuroepithelial cell differentiation(GO:0002085) |
0.1 | 0.3 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.3 | GO:0000089 | mitotic metaphase(GO:0000089) |
0.1 | 0.3 | GO:0070265 | necrotic cell death(GO:0070265) |
0.1 | 0.2 | GO:0002740 | negative regulation of cytokine secretion involved in immune response(GO:0002740) |
0.1 | 0.3 | GO:0007140 | male meiosis(GO:0007140) |
0.1 | 0.3 | GO:0045916 | negative regulation of humoral immune response(GO:0002921) negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.1 | 0.1 | GO:0032613 | interleukin-10 production(GO:0032613) |
0.1 | 0.3 | GO:0005997 | xylulose metabolic process(GO:0005997) |
0.1 | 0.4 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.1 | 0.3 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.2 | GO:0019228 | neuronal action potential(GO:0019228) |
0.1 | 0.4 | GO:0043628 | ncRNA 3'-end processing(GO:0043628) |
0.1 | 0.3 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.1 | 0.4 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.1 | 0.1 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.1 | 0.6 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.2 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.1 | 4.3 | GO:0097194 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) execution phase of apoptosis(GO:0097194) |
0.1 | 0.2 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 0.5 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
0.1 | 0.4 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.6 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.1 | 0.3 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.1 | 0.2 | GO:0043247 | protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
0.1 | 0.4 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.1 | 0.2 | GO:0035610 | C-terminal protein deglutamylation(GO:0035609) protein side chain deglutamylation(GO:0035610) |
0.1 | 0.2 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.1 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) metanephric mesenchymal cell differentiation(GO:0072162) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.1 | 0.1 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) |
0.1 | 0.1 | GO:0021554 | optic nerve development(GO:0021554) |
0.1 | 0.2 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.1 | 0.2 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 0.5 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.1 | 0.2 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) regulation of sodium ion transmembrane transport(GO:1902305) regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.1 | 0.2 | GO:0035751 | lysosomal lumen acidification(GO:0007042) regulation of lysosomal lumen pH(GO:0035751) |
0.1 | 0.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.1 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
0.1 | 0.2 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.1 | 0.2 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.1 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
0.1 | 0.8 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.3 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.1 | 0.3 | GO:0021707 | cerebellar granular layer development(GO:0021681) cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.1 | 0.2 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.1 | 0.3 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 0.2 | GO:0009301 | snRNA transcription(GO:0009301) |
0.1 | 1.1 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.1 | 0.3 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.1 | 1.3 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.1 | 0.2 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) regulation of transcription by glucose(GO:0046015) |
0.1 | 1.6 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 0.6 | GO:0006553 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.1 | 0.1 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.1 | 0.3 | GO:0051927 | obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
0.1 | 0.4 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.1 | 1.7 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.1 | 0.1 | GO:0070198 | protein localization to chromosome, telomeric region(GO:0070198) |
0.1 | 0.2 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.1 | 0.1 | GO:0032641 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
0.1 | 0.9 | GO:0045730 | respiratory burst(GO:0045730) |
0.1 | 0.1 | GO:0002823 | negative regulation of adaptive immune response(GO:0002820) negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains(GO:0002823) |
0.1 | 0.3 | GO:0070293 | renal absorption(GO:0070293) |
0.1 | 0.4 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.1 | 0.4 | GO:0016556 | mRNA modification(GO:0016556) |
0.1 | 0.1 | GO:0009215 | purine deoxyribonucleoside triphosphate metabolic process(GO:0009215) |
0.1 | 0.8 | GO:0016073 | snRNA metabolic process(GO:0016073) |
0.1 | 0.1 | GO:0042508 | tyrosine phosphorylation of Stat1 protein(GO:0042508) |
0.1 | 0.3 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.8 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 0.2 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.1 | 0.3 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.1 | 0.8 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.1 | 0.9 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.1 | 0.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 0.3 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.1 | 0.6 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.1 | 0.6 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.1 | 0.2 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
0.1 | 1.2 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.1 | 5.3 | GO:0018279 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 0.1 | GO:0060117 | auditory receptor cell development(GO:0060117) |
0.1 | 0.1 | GO:0060992 | response to fungicide(GO:0060992) |
0.1 | 0.1 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.1 | 0.3 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.1 | 0.2 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.1 | 0.1 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.1 | 0.1 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.1 | 0.1 | GO:0008049 | male courtship behavior(GO:0008049) |
0.1 | 0.3 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.1 | 0.3 | GO:0001832 | blastocyst growth(GO:0001832) |
0.1 | 0.1 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.1 | 0.4 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.1 | 0.5 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 0.2 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.1 | 0.3 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.1 | 0.3 | GO:0051567 | histone H3-K9 methylation(GO:0051567) histone H3-K9 modification(GO:0061647) |
0.1 | 0.1 | GO:0019731 | antimicrobial humoral response(GO:0019730) antibacterial humoral response(GO:0019731) |
0.1 | 0.4 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.3 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 0.5 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.7 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.1 | 2.5 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.2 | GO:0055015 | ventricular cardiac muscle cell development(GO:0055015) |
0.1 | 0.3 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.1 | 0.3 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.1 | 1.0 | GO:0018410 | C-terminal protein amino acid modification(GO:0018410) |
0.1 | 0.2 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.4 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.1 | 0.2 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.1 | 0.2 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.1 | 0.1 | GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling(GO:0010903) |
0.1 | 0.4 | GO:2000193 | positive regulation of fatty acid transport(GO:2000193) |
0.1 | 0.2 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.1 | 0.2 | GO:0051208 | sequestering of calcium ion(GO:0051208) |
0.1 | 0.5 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 0.1 | GO:0032094 | response to food(GO:0032094) |
0.1 | 0.2 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.1 | 0.2 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 | 0.2 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 0.5 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.1 | GO:0021801 | cerebral cortex radial glia guided migration(GO:0021801) layer formation in cerebral cortex(GO:0021819) telencephalon glial cell migration(GO:0022030) |
0.1 | 0.2 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.1 | 1.1 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.1 | 0.3 | GO:0015851 | nucleobase transport(GO:0015851) |
0.1 | 0.1 | GO:2001259 | positive regulation of calcium ion transmembrane transporter activity(GO:1901021) positive regulation of cation channel activity(GO:2001259) |
0.1 | 0.1 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.1 | 0.3 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.4 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.1 | 0.2 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) carnitine biosynthetic process(GO:0045329) |
0.1 | 0.3 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
0.1 | 0.2 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.1 | 0.1 | GO:0051797 | regulation of hair cycle(GO:0042634) positive regulation of hair cycle(GO:0042635) regulation of hair follicle development(GO:0051797) positive regulation of hair follicle development(GO:0051798) |
0.1 | 0.7 | GO:0045576 | mast cell activation(GO:0045576) |
0.1 | 1.5 | GO:1901185 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.1 | 0.2 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.1 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.1 | 0.1 | GO:0048087 | positive regulation of developmental pigmentation(GO:0048087) |
0.1 | 0.2 | GO:0006301 | postreplication repair(GO:0006301) |
0.1 | 1.3 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.1 | 0.2 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.1 | 0.1 | GO:0048865 | stem cell fate commitment(GO:0048865) stem cell fate determination(GO:0048867) |
0.1 | 0.1 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.1 | 0.3 | GO:0046605 | regulation of centrosome cycle(GO:0046605) |
0.1 | 0.2 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.1 | 0.3 | GO:0043555 | regulation of translation in response to stress(GO:0043555) regulation of translational initiation in response to stress(GO:0043558) |
0.1 | 0.2 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 0.2 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.1 | 0.6 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.2 | GO:0045007 | depurination(GO:0045007) |
0.1 | 0.1 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.1 | 0.3 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.1 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.1 | 0.2 | GO:0009804 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.1 | 0.1 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) microtubule anchoring at microtubule organizing center(GO:0072393) |
0.1 | 0.2 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.1 | 0.9 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.1 | 0.1 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.1 | 0.1 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.1 | 0.1 | GO:0090047 | obsolete positive regulation of transcription regulator activity(GO:0090047) |
0.1 | 0.4 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.1 | 0.1 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.1 | 0.2 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.1 | 0.9 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.1 | 0.1 | GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
0.1 | 0.1 | GO:0007412 | axon target recognition(GO:0007412) |
0.0 | 0.0 | GO:0022038 | corpus callosum development(GO:0022038) |
0.0 | 0.1 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.0 | 0.1 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.0 | 1.7 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.1 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.0 | 0.6 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.0 | 0.1 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.0 | 0.5 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.0 | 0.0 | GO:0032069 | regulation of nuclease activity(GO:0032069) |
0.0 | 0.3 | GO:0015886 | heme transport(GO:0015886) |
0.0 | 0.1 | GO:0001961 | positive regulation of cytokine-mediated signaling pathway(GO:0001961) |
0.0 | 0.9 | GO:0050870 | positive regulation of T cell activation(GO:0050870) positive regulation of leukocyte cell-cell adhesion(GO:1903039) |
0.0 | 6.1 | GO:0000375 | RNA splicing, via transesterification reactions(GO:0000375) |
0.0 | 0.1 | GO:0034370 | triglyceride-rich lipoprotein particle remodeling(GO:0034370) very-low-density lipoprotein particle remodeling(GO:0034372) |
0.0 | 0.2 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.0 | 0.0 | GO:0001302 | replicative cell aging(GO:0001302) |
0.0 | 0.1 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
0.0 | 0.1 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.0 | 0.2 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.0 | 0.8 | GO:0015807 | L-amino acid transport(GO:0015807) |
0.0 | 0.0 | GO:0052509 | modulation by symbiont of host defense response(GO:0052031) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) |
0.0 | 0.1 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.0 | 0.0 | GO:0051608 | histamine transport(GO:0051608) |
0.0 | 0.3 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.0 | 0.0 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.0 | 0.0 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.0 | 0.3 | GO:0035637 | transmission of nerve impulse(GO:0019226) multicellular organismal signaling(GO:0035637) |
0.0 | 0.2 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
0.0 | 0.7 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.0 | 0.1 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.0 | 0.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.0 | 0.3 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.0 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.0 | 0.1 | GO:0010916 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
0.0 | 0.2 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.0 | 0.1 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.0 | 0.0 | GO:0060430 | lung saccule development(GO:0060430) Type II pneumocyte differentiation(GO:0060510) |
0.0 | 0.6 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.1 | GO:0016048 | detection of temperature stimulus(GO:0016048) detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.0 | 0.0 | GO:0032677 | regulation of interleukin-8 production(GO:0032677) |
0.0 | 0.1 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.0 | 0.2 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) |
0.0 | 0.6 | GO:0050832 | defense response to fungus(GO:0050832) |
0.0 | 0.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.2 | GO:0060487 | lung epithelial cell differentiation(GO:0060487) |
0.0 | 0.0 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.0 | 2.0 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.0 | 0.1 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
0.0 | 0.1 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.3 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.0 | 0.2 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 0.1 | GO:0032106 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
0.0 | 0.1 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.0 | 0.4 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.0 | 1.1 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.1 | GO:0031297 | replication fork processing(GO:0031297) |
0.0 | 0.0 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) |
0.0 | 0.2 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.0 | 0.0 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.0 | 0.3 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.0 | 0.0 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.0 | 0.2 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.0 | 0.0 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.0 | 0.0 | GO:0060426 | lung vasculature development(GO:0060426) |
0.0 | 1.2 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
0.0 | 0.1 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.0 | 1.4 | GO:0006397 | mRNA processing(GO:0006397) |
0.0 | 0.1 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.0 | 0.0 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.0 | 0.4 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.0 | 0.0 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.0 | 0.1 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.0 | 0.2 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
0.0 | 0.2 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.0 | 0.5 | GO:0007379 | segment specification(GO:0007379) |
0.0 | 0.1 | GO:1903020 | positive regulation of glycoprotein biosynthetic process(GO:0010560) positive regulation of glycoprotein metabolic process(GO:1903020) |
0.0 | 0.2 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
0.0 | 0.2 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 0.1 | GO:0046877 | regulation of saliva secretion(GO:0046877) |
0.0 | 0.2 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.0 | 0.2 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.0 | 0.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 | 0.2 | GO:0061462 | protein targeting to lysosome(GO:0006622) protein targeting to vacuole(GO:0006623) protein localization to lysosome(GO:0061462) protein localization to vacuole(GO:0072665) establishment of protein localization to vacuole(GO:0072666) |
0.0 | 0.5 | GO:0001906 | cell killing(GO:0001906) |
0.0 | 0.1 | GO:0019605 | butyrate metabolic process(GO:0019605) |
0.0 | 0.1 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.0 | 0.2 | GO:0045040 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.0 | 0.0 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.0 | 0.1 | GO:0016559 | peroxisome fission(GO:0016559) |
0.0 | 0.7 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.0 | 3.0 | GO:0008380 | RNA splicing(GO:0008380) |
0.0 | 0.1 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.0 | 0.2 | GO:0032528 | microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
0.0 | 0.1 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.0 | 0.0 | GO:0035725 | sodium ion transmembrane transport(GO:0035725) |
0.0 | 0.2 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.0 | 0.0 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.0 | 0.2 | GO:0044409 | entry into host cell(GO:0030260) entry into host(GO:0044409) viral entry into host cell(GO:0046718) entry into cell of other organism involved in symbiotic interaction(GO:0051806) entry into other organism involved in symbiotic interaction(GO:0051828) |
0.0 | 0.1 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
0.0 | 0.3 | GO:0061515 | erythrocyte development(GO:0048821) myeloid cell development(GO:0061515) |
0.0 | 0.0 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.0 | 0.1 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.0 | 0.1 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.0 | 0.3 | GO:0000050 | urea cycle(GO:0000050) |
0.0 | 0.1 | GO:0032715 | negative regulation of interleukin-6 production(GO:0032715) |
0.0 | 0.5 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
0.0 | 0.3 | GO:0071242 | cellular response to ammonium ion(GO:0071242) |
0.0 | 0.1 | GO:0070828 | heterochromatin assembly(GO:0031507) heterochromatin organization(GO:0070828) |
0.0 | 0.1 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.0 | 0.2 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
0.0 | 0.0 | GO:0050701 | interleukin-1 secretion(GO:0050701) |
0.0 | 0.0 | GO:0030104 | water homeostasis(GO:0030104) |
0.0 | 0.1 | GO:0060251 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) regulation of glial cell proliferation(GO:0060251) negative regulation of glial cell proliferation(GO:0060253) |
0.0 | 0.2 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.0 | 0.1 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 1.1 | GO:0051607 | defense response to virus(GO:0051607) |
0.0 | 0.7 | GO:0006406 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.0 | 0.2 | GO:0046688 | response to copper ion(GO:0046688) |
0.0 | 0.1 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.0 | 0.1 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.0 | 0.0 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.0 | 0.2 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 0.1 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
0.0 | 0.1 | GO:0032098 | regulation of appetite(GO:0032098) |
0.0 | 0.1 | GO:0010165 | response to X-ray(GO:0010165) |
0.0 | 0.1 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.0 | 0.3 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.0 | 0.1 | GO:0051452 | intracellular pH reduction(GO:0051452) |
0.0 | 0.6 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.0 | 0.6 | GO:0021549 | cerebellum development(GO:0021549) |
0.0 | 0.1 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.0 | 0.3 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.0 | 0.5 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.0 | 0.9 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) |
0.0 | 0.1 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.0 | 0.2 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.0 | 3.5 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.0 | 0.3 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.0 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.0 | 0.0 | GO:1905209 | positive regulation of cardioblast differentiation(GO:0051891) positive regulation of cardiocyte differentiation(GO:1905209) |
0.0 | 0.2 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.0 | 0.2 | GO:0030277 | epithelial structure maintenance(GO:0010669) maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.2 | GO:0071230 | cellular response to amino acid stimulus(GO:0071230) |
0.0 | 0.3 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.0 | 0.1 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.0 | 0.1 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.0 | 0.2 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.1 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.0 | 0.0 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.0 | 0.2 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.0 | 0.2 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 1.3 | GO:0007498 | mesoderm development(GO:0007498) |
0.0 | 0.1 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
0.0 | 0.1 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.0 | 0.3 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.0 | 0.1 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.0 | 0.1 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.0 | 1.5 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.0 | 0.9 | GO:0034340 | response to type I interferon(GO:0034340) |
0.0 | 0.1 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.0 | 0.3 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.0 | 0.1 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.0 | 0.1 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.0 | 0.1 | GO:0040018 | positive regulation of multicellular organism growth(GO:0040018) |
0.0 | 0.2 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.2 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.0 | 0.1 | GO:0045006 | DNA deamination(GO:0045006) |
0.0 | 0.2 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.0 | 0.1 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
0.0 | 0.1 | GO:0010288 | response to lead ion(GO:0010288) |
0.0 | 0.2 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.0 | 0.2 | GO:0000085 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.0 | 0.1 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.1 | GO:0007090 | obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
0.0 | 0.0 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.0 | 0.1 | GO:0021532 | neural tube patterning(GO:0021532) |
0.0 | 0.0 | GO:0034698 | response to gonadotropin(GO:0034698) |
0.0 | 0.3 | GO:0000080 | mitotic G1 phase(GO:0000080) |
0.0 | 2.9 | GO:0006470 | protein dephosphorylation(GO:0006470) |
0.0 | 0.2 | GO:0006833 | water transport(GO:0006833) |
0.0 | 0.3 | GO:0044036 | cell wall macromolecule catabolic process(GO:0016998) cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.0 | 0.1 | GO:0048535 | lymph node development(GO:0048535) |
0.0 | 0.2 | GO:0046415 | urate metabolic process(GO:0046415) |
0.0 | 0.1 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.0 | 0.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.0 | 0.1 | GO:0071941 | nitrogen cycle metabolic process(GO:0071941) |
0.0 | 0.0 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.0 | 0.4 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) |
0.0 | 0.6 | GO:0072512 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
0.0 | 0.1 | GO:0006903 | vesicle targeting(GO:0006903) |
0.0 | 0.1 | GO:0000239 | pachytene(GO:0000239) |
0.0 | 0.0 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.0 | 0.1 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.0 | 0.4 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.7 | GO:0000216 | obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
0.0 | 0.0 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.0 | 0.9 | GO:0034339 | obsolete regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor(GO:0034339) |
0.0 | 0.1 | GO:0045683 | negative regulation of epidermal cell differentiation(GO:0045605) negative regulation of keratinocyte differentiation(GO:0045617) negative regulation of epidermis development(GO:0045683) |
0.0 | 0.2 | GO:0043545 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.0 | 0.4 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.2 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.0 | 0.4 | GO:0007032 | endosome organization(GO:0007032) |
0.0 | 0.1 | GO:0021513 | spinal cord dorsal/ventral patterning(GO:0021513) |
0.0 | 0.1 | GO:0000154 | rRNA modification(GO:0000154) |
0.0 | 0.2 | GO:0021522 | ventral spinal cord development(GO:0021517) spinal cord motor neuron differentiation(GO:0021522) |
0.0 | 0.2 | GO:0050715 | positive regulation of cytokine secretion(GO:0050715) |
0.0 | 0.1 | GO:0051298 | centrosome duplication(GO:0051298) |
0.0 | 0.0 | GO:0001820 | serotonin secretion(GO:0001820) |
0.0 | 0.3 | GO:0043574 | peroxisomal transport(GO:0043574) |
0.0 | 0.0 | GO:0003099 | regulation of the force of heart contraction by chemical signal(GO:0003057) positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
0.0 | 0.1 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.0 | 0.1 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.0 | 0.0 | GO:0072109 | glomerular mesangium development(GO:0072109) |
0.0 | 0.2 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.0 | 0.3 | GO:0034762 | regulation of transmembrane transport(GO:0034762) |
0.0 | 0.1 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.0 | 0.1 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.1 | GO:0000956 | nuclear-transcribed mRNA catabolic process(GO:0000956) |
0.0 | 0.2 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.0 | 0.0 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.0 | 0.0 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.0 | 0.2 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.0 | 0.1 | GO:0071166 | ribonucleoprotein complex localization(GO:0071166) |
0.0 | 0.0 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.0 | 0.0 | GO:0045851 | pH reduction(GO:0045851) |
0.0 | 0.1 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.0 | 0.4 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.0 | 0.0 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.0 | 0.1 | GO:0048664 | neuron fate determination(GO:0048664) |
0.0 | 0.0 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.0 | 0.1 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.1 | GO:0046321 | positive regulation of fatty acid oxidation(GO:0046321) |
0.0 | 0.8 | GO:0006413 | translational initiation(GO:0006413) |
0.0 | 0.3 | GO:0009303 | rRNA transcription(GO:0009303) |
0.0 | 0.0 | GO:0051197 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of nucleoside metabolic process(GO:0045979) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) positive regulation of ATP metabolic process(GO:1903580) |
0.0 | 0.1 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.0 | 0.1 | GO:0002002 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin(GO:0001991) regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
0.0 | 0.2 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.0 | 0.2 | GO:0031280 | negative regulation of adenylate cyclase activity(GO:0007194) negative regulation of cyclase activity(GO:0031280) negative regulation of lyase activity(GO:0051350) |
0.0 | 0.0 | GO:0060014 | granulosa cell differentiation(GO:0060014) |
0.0 | 0.1 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.0 | 0.1 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.0 | 0.0 | GO:0019042 | viral latency(GO:0019042) |
0.0 | 0.0 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.0 | 5.7 | GO:0006412 | translation(GO:0006412) |
0.0 | 0.1 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.0 | 0.1 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.0 | 0.0 | GO:0009084 | glutamine family amino acid biosynthetic process(GO:0009084) |
0.0 | 0.4 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.5 | GO:0000187 | activation of MAPK activity(GO:0000187) |
0.0 | 0.0 | GO:0014044 | Schwann cell development(GO:0014044) |
0.0 | 0.0 | GO:0051928 | positive regulation of calcium ion transport(GO:0051928) |
0.0 | 0.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.0 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.0 | 0.1 | GO:0002920 | regulation of humoral immune response(GO:0002920) |
0.0 | 0.0 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.1 | GO:0008218 | bioluminescence(GO:0008218) |
0.0 | 0.1 | GO:0015904 | tetracycline transport(GO:0015904) antibiotic transport(GO:0042891) toxin transport(GO:1901998) |
0.0 | 0.0 | GO:0051383 | kinetochore organization(GO:0051383) |
0.0 | 0.0 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.0 | 0.2 | GO:1901071 | glucosamine-containing compound metabolic process(GO:1901071) |
0.0 | 0.0 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.0 | 0.0 | GO:0045822 | negative regulation of heart contraction(GO:0045822) |
0.0 | 0.0 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.0 | 0.1 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.0 | 0.1 | GO:0010524 | positive regulation of calcium ion transport into cytosol(GO:0010524) |
0.0 | 0.0 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.0 | 0.0 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.0 | 0.0 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.0 | 0.1 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.0 | 0.1 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.0 | 0.1 | GO:0071569 | protein ufmylation(GO:0071569) |
0.0 | 0.0 | GO:0021894 | interneuron migration from the subpallium to the cortex(GO:0021830) cerebral cortex GABAergic interneuron migration(GO:0021853) cerebral cortex GABAergic interneuron development(GO:0021894) interneuron migration(GO:1904936) |
0.0 | 0.1 | GO:0002456 | T cell mediated immunity(GO:0002456) |
0.0 | 0.9 | GO:0006364 | rRNA processing(GO:0006364) |
0.0 | 0.0 | GO:0043049 | otic placode formation(GO:0043049) |
0.0 | 2.1 | GO:0006457 | protein folding(GO:0006457) |
0.0 | 0.2 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.3 | GO:0070588 | calcium ion transmembrane transport(GO:0070588) |
0.0 | 0.0 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.0 | 0.0 | GO:0015791 | polyol transport(GO:0015791) |
0.0 | 0.8 | GO:0009615 | response to virus(GO:0009615) |
0.0 | 0.0 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.0 | 0.1 | GO:0009249 | protein lipoylation(GO:0009249) |
0.0 | 0.0 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.0 | 0.0 | GO:0032945 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
0.0 | 0.0 | GO:0032367 | intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
0.0 | 0.1 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.0 | 0.1 | GO:0042423 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.0 | 0.3 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 0.0 | GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
0.0 | 0.0 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.0 | 0.1 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.0 | 0.1 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.0 | 0.0 | GO:0060291 | long-term synaptic potentiation(GO:0060291) |
0.0 | 0.2 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.0 | 0.0 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.0 | 0.0 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.0 | 0.1 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.0 | 0.1 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
0.0 | 0.1 | GO:0043526 | obsolete neuroprotection(GO:0043526) |
0.0 | 0.0 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.0 | 0.0 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.0 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.0 | 0.0 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.0 | 0.0 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.0 | 0.0 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.0 | 0.3 | GO:0071804 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.0 | 0.2 | GO:0016571 | histone methylation(GO:0016571) |
0.0 | 0.0 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.1 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 0.0 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.0 | 0.2 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.0 | 0.0 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.0 | 0.1 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 0.0 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) |
0.0 | 0.0 | GO:1903115 | regulation of muscle filament sliding(GO:0032971) regulation of actin filament-based movement(GO:1903115) |
0.0 | 0.5 | GO:0008203 | cholesterol metabolic process(GO:0008203) |
0.0 | 0.0 | GO:0007127 | meiosis I(GO:0007127) |
0.0 | 0.2 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.0 | 0.1 | GO:0032042 | mitochondrial DNA metabolic process(GO:0032042) |
0.0 | 0.2 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.0 | 0.0 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.0 | 0.0 | GO:0072111 | cell proliferation involved in kidney development(GO:0072111) |
0.0 | 0.0 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
0.0 | 0.2 | GO:0030856 | regulation of epithelial cell differentiation(GO:0030856) |
0.0 | 0.0 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.0 | 0.1 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.0 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.0 | 0.1 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.0 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.0 | 0.0 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.0 | 0.0 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.0 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.0 | 0.0 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.0 | 0.2 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
0.0 | 0.0 | GO:0032418 | lysosome localization(GO:0032418) |
0.0 | 0.0 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.0 | 0.1 | GO:0030317 | sperm motility(GO:0030317) |
0.0 | 0.1 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.0 | 0.0 | GO:0071459 | protein localization to kinetochore(GO:0034501) protein localization to chromosome, centromeric region(GO:0071459) |
0.0 | 0.0 | GO:0032409 | regulation of transporter activity(GO:0032409) |
0.0 | 0.1 | GO:0006546 | glycine catabolic process(GO:0006546) |
0.0 | 4.3 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.0 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.0 | 0.0 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.1 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.0 | 0.0 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.0 | 0.0 | GO:0035082 | axoneme assembly(GO:0035082) |
0.0 | 0.1 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.0 | 0.0 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
0.0 | 0.4 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.0 | 0.0 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.0 | 0.1 | GO:0051324 | prophase(GO:0051324) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 2.8 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.5 | 2.2 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.4 | 3.6 | GO:0001891 | phagocytic cup(GO:0001891) |
0.4 | 1.2 | GO:0071942 | XPC complex(GO:0071942) |
0.3 | 1.9 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.3 | 0.9 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.3 | 0.9 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.3 | 0.5 | GO:0033270 | paranode region of axon(GO:0033270) |
0.3 | 0.8 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.2 | 1.0 | GO:0005827 | polar microtubule(GO:0005827) |
0.2 | 2.8 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.2 | 2.2 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.2 | 0.6 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.2 | 2.2 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 2.8 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 0.4 | GO:0031313 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.2 | 0.2 | GO:0031932 | TORC2 complex(GO:0031932) |
0.2 | 0.8 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.2 | 0.9 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.2 | 0.7 | GO:0098984 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.2 | 0.7 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.2 | 0.5 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.2 | 0.8 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.2 | 0.5 | GO:0072487 | MSL complex(GO:0072487) |
0.2 | 0.6 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.2 | 2.3 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.2 | 0.9 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.1 | 0.9 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.1 | 1.5 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 0.9 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.1 | 0.9 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.1 | 0.4 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 1.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 1.2 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 2.7 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 4.2 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 0.5 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 0.8 | GO:0000805 | X chromosome(GO:0000805) |
0.1 | 0.5 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.1 | 0.7 | GO:0000791 | euchromatin(GO:0000791) |
0.1 | 0.7 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 0.1 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.8 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.1 | 0.3 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.1 | 0.5 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 3.6 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.1 | 1.2 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 0.7 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 0.6 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.1 | 0.4 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 0.4 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 0.4 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 0.3 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 1.5 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 0.5 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.5 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 1.7 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.1 | 1.2 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.1 | 4.5 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 1.2 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 0.7 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 0.8 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 0.5 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 0.3 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 0.3 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 1.3 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 0.8 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 0.4 | GO:0000800 | lateral element(GO:0000800) |
0.1 | 0.8 | GO:0016585 | obsolete chromatin remodeling complex(GO:0016585) |
0.1 | 1.3 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.1 | 0.9 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.1 | 0.6 | GO:0016604 | nuclear body(GO:0016604) |
0.1 | 0.8 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.3 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.1 | 0.4 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.3 | GO:0001741 | XY body(GO:0001741) |
0.1 | 0.6 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 1.7 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 2.0 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 0.5 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 0.2 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.1 | 0.5 | GO:0005795 | Golgi stack(GO:0005795) |
0.1 | 0.7 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.8 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 1.0 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 0.2 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.1 | 0.2 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.1 | 0.4 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 0.2 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 1.5 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 0.4 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 1.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.6 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.6 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.4 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 0.6 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 0.4 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 0.1 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.1 | 0.3 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 0.2 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 1.6 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 0.6 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 0.7 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 2.6 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 3.1 | GO:0016605 | PML body(GO:0016605) |
0.1 | 0.9 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.1 | 0.1 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.1 | 0.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.2 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.1 | 0.4 | GO:0005678 | obsolete chromatin assembly complex(GO:0005678) |
0.1 | 0.4 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
0.1 | 0.4 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.1 | 0.2 | GO:0070188 | obsolete Stn1-Ten1 complex(GO:0070188) |
0.1 | 0.2 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 0.9 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 0.3 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 0.4 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 6.8 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 0.9 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.3 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 0.4 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 0.3 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 0.1 | GO:0042827 | platelet dense granule(GO:0042827) |
0.1 | 0.2 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.1 | 1.1 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 0.1 | GO:0032155 | cell division site(GO:0032153) cell division site part(GO:0032155) |
0.1 | 0.2 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 1.0 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 0.4 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 0.3 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.1 | 2.0 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 2.4 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.0 | 0.2 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 0.2 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.0 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.0 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.0 | 0.2 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.0 | 1.4 | GO:0005814 | centriole(GO:0005814) |
0.0 | 0.9 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.0 | 0.2 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.0 | 0.0 | GO:0030686 | 90S preribosome(GO:0030686) |
0.0 | 4.3 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 0.4 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.4 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.2 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.0 | 0.4 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.0 | 0.2 | GO:0000346 | transcription export complex(GO:0000346) |
0.0 | 0.4 | GO:0008278 | cohesin complex(GO:0008278) |
0.0 | 1.3 | GO:0034708 | methyltransferase complex(GO:0034708) histone methyltransferase complex(GO:0035097) |
0.0 | 1.1 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.0 | 0.4 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.0 | 0.0 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 0.2 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 0.2 | GO:0031672 | A band(GO:0031672) |
0.0 | 0.3 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.0 | 0.2 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.2 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.1 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.1 | GO:0031082 | BLOC complex(GO:0031082) BLOC-1 complex(GO:0031083) |
0.0 | 0.1 | GO:0031501 | mannosyltransferase complex(GO:0031501) dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.0 | 0.1 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 1.0 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.0 | GO:0070820 | tertiary granule(GO:0070820) |
0.0 | 1.7 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 0.2 | GO:0000792 | heterochromatin(GO:0000792) |
0.0 | 0.1 | GO:0033150 | cytoskeletal calyx(GO:0033150) |
0.0 | 0.2 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 0.9 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.0 | GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.0 | 0.4 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 1.3 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.1 | GO:0001652 | granular component(GO:0001652) |
0.0 | 0.0 | GO:0001939 | female pronucleus(GO:0001939) |
0.0 | 0.3 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.0 | 0.3 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.0 | 0.6 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 0.3 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.4 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 1.0 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.0 | 0.0 | GO:0071564 | npBAF complex(GO:0071564) |
0.0 | 0.3 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 3.9 | GO:0000785 | chromatin(GO:0000785) |
0.0 | 0.1 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.0 | 2.1 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.0 | 0.4 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.0 | 0.1 | GO:0016600 | flotillin complex(GO:0016600) |
0.0 | 0.4 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.0 | 1.1 | GO:0030286 | dynein complex(GO:0030286) |
0.0 | 0.4 | GO:0005844 | polysome(GO:0005844) |
0.0 | 0.5 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 0.2 | GO:0061200 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.0 | 0.2 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) |
0.0 | 0.3 | GO:0042597 | outer membrane-bounded periplasmic space(GO:0030288) periplasmic space(GO:0042597) |
0.0 | 0.0 | GO:0033011 | perinuclear theca(GO:0033011) |
0.0 | 0.1 | GO:0042825 | TAP complex(GO:0042825) |
0.0 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 0.1 | GO:0031904 | endosome lumen(GO:0031904) |
0.0 | 0.1 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 3.1 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 0.1 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.0 | 0.2 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.0 | 1.2 | GO:0000502 | proteasome complex(GO:0000502) |
0.0 | 0.4 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.4 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
0.0 | 0.5 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.0 | 2.1 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 0.1 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.0 | 0.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.0 | 0.2 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 0.8 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.5 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 0.1 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.0 | 0.1 | GO:0043230 | extracellular organelle(GO:0043230) extracellular exosome(GO:0070062) extracellular vesicle(GO:1903561) |
0.0 | 0.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 0.1 | GO:0045120 | pronucleus(GO:0045120) |
0.0 | 0.2 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.0 | 0.1 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.2 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.0 | 0.3 | GO:0005903 | brush border(GO:0005903) |
0.0 | 0.1 | GO:0031528 | microvillus membrane(GO:0031528) |
0.0 | 0.6 | GO:0015934 | large ribosomal subunit(GO:0015934) |
0.0 | 0.7 | GO:0009295 | nucleoid(GO:0009295) |
0.0 | 0.0 | GO:0030312 | external encapsulating structure(GO:0030312) external encapsulating structure part(GO:0044462) |
0.0 | 0.7 | GO:0031461 | cullin-RING ubiquitin ligase complex(GO:0031461) |
0.0 | 0.5 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 0.0 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.0 | 0.1 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 3.3 | GO:0005768 | endosome(GO:0005768) |
0.0 | 9.6 | GO:0005654 | nucleoplasm(GO:0005654) |
0.0 | 0.1 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.0 | 0.6 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.0 | 0.2 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 12.8 | GO:0005730 | nucleolus(GO:0005730) |
0.0 | 0.2 | GO:0034706 | sodium channel complex(GO:0034706) |
0.0 | 0.6 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.0 | 2.9 | GO:0009986 | cell surface(GO:0009986) |
0.0 | 2.4 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 0.0 | GO:1990777 | protein-lipid complex(GO:0032994) plasma lipoprotein particle(GO:0034358) lipoprotein particle(GO:1990777) |
0.0 | 0.1 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.7 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 0.0 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.1 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.4 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.4 | GO:0031970 | organelle envelope lumen(GO:0031970) |
0.0 | 4.6 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 0.1 | GO:0016234 | inclusion body(GO:0016234) |
0.0 | 0.1 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 2.5 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 0.0 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 6.4 | GO:0042175 | nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.0 | 0.0 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.0 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.0 | GO:0043235 | receptor complex(GO:0043235) |
0.0 | 1.1 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 0.0 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.0 | 0.2 | GO:0030496 | midbody(GO:0030496) |
0.0 | 37.9 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 2.0 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.0 | 0.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 0.1 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.0 | 36.4 | GO:0016021 | integral component of membrane(GO:0016021) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.5 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.6 | 1.7 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.5 | 1.6 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.5 | 1.6 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.4 | 1.3 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.4 | 2.1 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.4 | 1.6 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.4 | 2.3 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.4 | 1.1 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.4 | 4.5 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.4 | 2.2 | GO:0005521 | lamin binding(GO:0005521) |
0.4 | 0.7 | GO:0004527 | exonuclease activity(GO:0004527) |
0.3 | 1.7 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.3 | 1.0 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.3 | 1.0 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.3 | 1.0 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.3 | 1.0 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.3 | 0.9 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.3 | 2.9 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.3 | 2.0 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.3 | 6.3 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.3 | 0.8 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.3 | 0.8 | GO:0033691 | sialic acid binding(GO:0033691) |
0.3 | 2.3 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.2 | 1.7 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.2 | 0.7 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.2 | 1.4 | GO:0050733 | RS domain binding(GO:0050733) |
0.2 | 0.7 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.2 | 1.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.2 | 0.9 | GO:0015925 | galactosidase activity(GO:0015925) |
0.2 | 0.6 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.2 | 0.6 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.2 | 1.9 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.2 | 0.4 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.2 | 0.6 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.2 | 0.6 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.2 | 3.0 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.2 | 2.2 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.2 | 0.5 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.2 | 0.7 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.2 | 0.7 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.2 | 0.7 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.2 | 2.4 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.2 | 1.0 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.2 | 0.8 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.2 | 0.5 | GO:0004875 | complement receptor activity(GO:0004875) |
0.2 | 0.8 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 0.5 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.2 | 0.5 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.2 | 1.9 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.2 | 0.6 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.2 | 0.6 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.2 | 0.5 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.2 | 2.8 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.2 | 1.2 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.6 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.1 | 0.4 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 0.1 | GO:0019959 | C-X-C chemokine binding(GO:0019958) interleukin-8 binding(GO:0019959) |
0.1 | 1.0 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.1 | 0.6 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 1.0 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 1.8 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.6 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.1 | 0.4 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 0.4 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.1 | 0.1 | GO:0016896 | exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
0.1 | 5.3 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 1.1 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.6 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 0.4 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.1 | 0.1 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.1 | 3.6 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 1.1 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.1 | 6.3 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 1.8 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 0.7 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 1.0 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.1 | 0.9 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 4.7 | GO:0101005 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.1 | 0.4 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 0.6 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.1 | 0.5 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 1.0 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.1 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.2 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.1 | 0.8 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.2 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.1 | 0.5 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 0.5 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 0.3 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.1 | 0.2 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 0.1 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.1 | 0.6 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 6.1 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 0.7 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 0.3 | GO:0004802 | transketolase activity(GO:0004802) |
0.1 | 1.0 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.1 | 0.3 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 0.3 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.1 | 0.5 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.9 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.1 | 1.5 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 0.3 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.1 | 0.3 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.1 | 0.5 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.1 | 0.4 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 0.3 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.1 | 1.4 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 0.6 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 0.9 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 0.4 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 0.6 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 0.3 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 0.8 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.1 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.1 | 1.1 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 0.7 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 1.0 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.1 | 0.6 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 0.9 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 0.7 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.1 | 0.4 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 2.7 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 0.5 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.1 | 0.8 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 0.4 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 0.5 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 2.8 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 0.6 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.1 | 0.4 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 0.9 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.1 | 1.9 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 0.8 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.1 | 0.2 | GO:0060230 | lipase activator activity(GO:0060229) lipoprotein lipase activator activity(GO:0060230) |
0.1 | 0.3 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.1 | 0.5 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 1.1 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 0.2 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) |
0.1 | 0.3 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 4.7 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 0.3 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.9 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 2.6 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.1 | 0.8 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.3 | GO:0000739 | obsolete DNA strand annealing activity(GO:0000739) |
0.1 | 1.5 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 0.3 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.1 | 0.9 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.3 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.1 | 0.3 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.1 | 1.4 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 0.4 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 0.3 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 0.1 | GO:0003896 | DNA primase activity(GO:0003896) |
0.1 | 2.2 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 0.9 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.1 | 0.3 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 0.2 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.1 | 0.3 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 0.7 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.1 | 0.2 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.1 | 0.9 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.2 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.1 | 0.6 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 0.3 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.1 | 1.1 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 0.2 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.1 | 0.2 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 0.2 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.1 | 1.4 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 0.4 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.2 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.1 | 0.2 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 1.6 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 2.5 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 2.5 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.1 | 0.3 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.1 | 0.2 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.4 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.6 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 0.6 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.4 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 0.6 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 0.6 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 0.1 | GO:0048156 | tau protein binding(GO:0048156) |
0.1 | 0.3 | GO:0031013 | troponin I binding(GO:0031013) |
0.1 | 0.3 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.1 | 0.1 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.1 | 0.1 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.1 | 0.3 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.2 | GO:0045159 | myosin II binding(GO:0045159) |
0.1 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 1.8 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.3 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.1 | 0.2 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 0.3 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.7 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.1 | 0.2 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.1 | 0.3 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 0.5 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.2 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.1 | 0.7 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 0.2 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 0.2 | GO:0004476 | mannose-6-phosphate isomerase activity(GO:0004476) |
0.1 | 0.2 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 1.1 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.1 | 1.0 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.1 | 2.1 | GO:0004221 | obsolete ubiquitin thiolesterase activity(GO:0004221) |
0.1 | 0.2 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.1 | GO:0015205 | nucleobase transmembrane transporter activity(GO:0015205) |
0.1 | 0.6 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 0.3 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.1 | 5.4 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 0.2 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.1 | 0.2 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 0.3 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.4 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 0.2 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 0.1 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.1 | 0.2 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 0.1 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 0.2 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.1 | 0.5 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.3 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 0.2 | GO:0004437 | obsolete inositol or phosphatidylinositol phosphatase activity(GO:0004437) |
0.1 | 1.0 | GO:0019239 | deaminase activity(GO:0019239) |
0.1 | 0.3 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 0.2 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
0.1 | 0.2 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.4 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 0.3 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
0.1 | 1.1 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.1 | 0.1 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.1 | 0.9 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.3 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 0.2 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.3 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.1 | 0.2 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 0.6 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.7 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.1 | 0.1 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.1 | 2.5 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 0.1 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.1 | 0.2 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 0.4 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 0.5 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 0.2 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 0.2 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.3 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.1 | 0.2 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.1 | 0.1 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.1 | 0.2 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 0.2 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.2 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.1 | 0.2 | GO:0019863 | IgE binding(GO:0019863) |
0.1 | 0.8 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.1 | 0.1 | GO:0043398 | HLH domain binding(GO:0043398) |
0.1 | 0.5 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.1 | 1.2 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.1 | 0.1 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.0 | 0.3 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.0 | 0.2 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) bisphosphoglycerate 2-phosphatase activity(GO:0004083) phosphoglycerate mutase activity(GO:0004619) |
0.0 | 0.0 | GO:0004516 | nicotinate phosphoribosyltransferase activity(GO:0004516) |
0.0 | 0.1 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.0 | 0.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.0 | 0.2 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.0 | 0.1 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.0 | 0.3 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 2.4 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.0 | 1.1 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.0 | 0.2 | GO:0080030 | methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.0 | 0.1 | GO:0051637 | obsolete Gram-positive bacterial cell surface binding(GO:0051637) |
0.0 | 1.7 | GO:0008137 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 1.2 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.0 | 0.1 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.0 | 0.2 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.0 | 0.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.0 | 0.1 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.0 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.1 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.0 | 0.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.3 | GO:0015923 | mannosidase activity(GO:0015923) |
0.0 | 0.8 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.1 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 0.3 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.0 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
0.0 | 0.0 | GO:0015421 | oligopeptide-transporting ATPase activity(GO:0015421) peptide-transporting ATPase activity(GO:0015440) |
0.0 | 0.2 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 0.1 | GO:0033265 | choline binding(GO:0033265) |
0.0 | 0.2 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.3 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.2 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.1 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 1.4 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 0.1 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.0 | 0.0 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 0.0 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 0.2 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 0.3 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 0.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.0 | 0.0 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.0 | 0.1 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.0 | 0.2 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 0.3 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.0 | 12.0 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.1 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.0 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.2 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.0 | 0.2 | GO:0005048 | signal sequence binding(GO:0005048) |
0.0 | 0.1 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.0 | 0.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.0 | 0.3 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.0 | 0.1 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.0 | 0.1 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 0.1 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 0.1 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.0 | 0.1 | GO:0001848 | complement binding(GO:0001848) |
0.0 | 0.1 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.0 | 0.2 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.7 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.2 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.1 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.0 | 0.1 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.4 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.7 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.3 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 0.2 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.1 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.0 | 0.5 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.1 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.0 | 0.1 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.0 | 0.3 | GO:0043621 | protein self-association(GO:0043621) |
0.0 | 0.7 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.0 | 0.3 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.1 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.0 | 0.8 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 0.4 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.2 | GO:0034979 | NAD-dependent histone deacetylase activity(GO:0017136) histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) histone deacetylase activity (H3-K9 specific)(GO:0032129) histone deacetylase activity (H4-K16 specific)(GO:0034739) NAD-dependent protein deacetylase activity(GO:0034979) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) NAD-dependent histone deacetylase activity (H4-K16 specific)(GO:0046970) |
0.0 | 0.2 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.2 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
0.0 | 0.1 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.0 | 0.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.0 | 0.4 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.0 | 0.6 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.4 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.5 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.0 | 0.2 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.0 | 0.1 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 0.4 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.0 | 0.1 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.0 | 0.0 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.1 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 0.2 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.0 | 0.1 | GO:0015250 | water channel activity(GO:0015250) |
0.0 | 0.1 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.0 | 0.1 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.0 | 0.2 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) |
0.0 | 0.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.1 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.0 | 0.5 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.2 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 1.0 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.1 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.0 | 0.2 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.0 | 0.0 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.0 | 0.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.0 | 0.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.2 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.1 | GO:0003701 | obsolete RNA polymerase I transcription factor activity(GO:0003701) |
0.0 | 0.1 | GO:0042806 | fucose binding(GO:0042806) |
0.0 | 0.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.0 | 0.1 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 0.2 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.0 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 0.3 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.0 | 0.5 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 12.9 | GO:0003723 | RNA binding(GO:0003723) |
0.0 | 1.2 | GO:0070035 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.0 | 0.1 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.0 | 0.0 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
0.0 | 0.1 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.0 | 0.2 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.0 | 0.2 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.0 | 0.1 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.2 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 0.1 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.1 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.0 | 0.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.8 | GO:0005319 | lipid transporter activity(GO:0005319) |
0.0 | 0.0 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.0 | 0.3 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 2.5 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.0 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 0.3 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.0 | 0.2 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.1 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.0 | 0.8 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.6 | GO:0019205 | nucleobase-containing compound kinase activity(GO:0019205) |
0.0 | 0.2 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.0 | 0.0 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.0 | 0.1 | GO:0051184 | cofactor transporter activity(GO:0051184) |
0.0 | 0.1 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 0.0 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.0 | 0.3 | GO:0043499 | obsolete eukaryotic cell surface binding(GO:0043499) |
0.0 | 1.1 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.0 | 0.2 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.0 | 0.1 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.0 | 0.4 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.0 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.0 | 0.4 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 0.3 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.0 | 0.6 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.1 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.0 | 0.0 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.0 | 0.2 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.0 | 0.1 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.0 | 0.3 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.0 | 0.1 | GO:0016160 | alpha-amylase activity(GO:0004556) amylase activity(GO:0016160) |
0.0 | 0.0 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.1 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.0 | 0.2 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 0.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.1 | GO:0035586 | purinergic receptor activity(GO:0035586) |
0.0 | 1.4 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.3 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.0 | 0.0 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.0 | 0.8 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.0 | 0.1 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.2 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.0 | GO:0004103 | choline kinase activity(GO:0004103) |
0.0 | 0.6 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) ubiquitin-like protein ligase binding(GO:0044389) |
0.0 | 0.2 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 0.1 | GO:0051861 | glycolipid binding(GO:0051861) |
0.0 | 0.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.5 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.0 | 0.1 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.0 | 0.3 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.1 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.0 | 0.0 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 0.0 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.0 | 0.0 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.0 | 1.1 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 0.0 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.0 | 0.0 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
0.0 | 27.0 | GO:0003677 | DNA binding(GO:0003677) |
0.0 | 0.1 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 0.0 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.0 | 0.0 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.0 | 0.1 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 3.0 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.0 | 0.0 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 0.1 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) |
0.0 | 0.1 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.0 | GO:0019956 | chemokine binding(GO:0019956) |
0.0 | 0.0 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.0 | 0.0 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.0 | 0.1 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.0 | 0.0 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.0 | 0.3 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.0 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.0 | 0.0 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.2 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.1 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.1 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.0 | 0.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.3 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.0 | 0.2 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.0 | 0.0 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.0 | 0.0 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.0 | 0.1 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 0.1 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.0 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.0 | 0.0 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.0 | 0.0 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.0 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.0 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.0 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 4.0 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.0 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.0 | 0.0 | GO:0045182 | translation regulator activity(GO:0045182) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 21.9 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.3 | 3.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.3 | 5.6 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.3 | 2.9 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.2 | 6.5 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.2 | 3.4 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.2 | 2.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.2 | 7.8 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.2 | 5.3 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 0.5 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.2 | 0.2 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.2 | 4.2 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.2 | 5.0 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 2.5 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.2 | 0.3 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 1.3 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.2 | 3.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.2 | 6.9 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.2 | 2.6 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 2.7 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 1.3 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 1.9 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 0.8 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 2.3 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 3.0 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 1.0 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 2.4 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 2.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 2.9 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 0.4 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 0.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 3.5 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 1.0 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 0.7 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 0.3 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 0.2 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 0.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 0.5 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 2.9 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 1.0 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 1.5 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 0.4 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 0.9 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 0.7 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 0.9 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 0.4 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 0.8 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 2.0 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 0.7 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 0.3 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 1.6 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 0.3 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 0.8 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 0.8 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 0.3 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 0.5 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 0.9 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 0.3 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.8 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.0 | ST STAT3 PATHWAY | STAT3 Pathway |
0.0 | 1.0 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.6 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.7 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.2 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 0.2 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.0 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.7 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 1.9 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.3 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 1.3 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.4 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.2 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.7 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.7 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.2 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.6 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 1.2 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.9 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.3 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.2 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 0.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.6 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.8 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.1 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.1 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 0.0 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.4 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.2 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.1 | ST GAQ PATHWAY | G alpha q Pathway |
0.0 | 0.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.0 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 1.3 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.3 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 0.2 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.0 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.2 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.0 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.2 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 8.4 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.5 | 4.3 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.5 | 1.6 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.5 | 7.9 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.3 | 3.1 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.3 | 4.5 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.2 | 3.5 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.2 | 0.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.2 | 7.3 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.2 | 2.9 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.2 | 3.7 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 2.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 4.3 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.2 | 4.2 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.2 | 5.3 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.2 | 1.5 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.2 | 0.6 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.2 | 7.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 1.2 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.2 | 5.0 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 2.0 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 0.7 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 0.1 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.1 | 0.7 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 2.8 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.1 | 1.9 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.1 | 1.7 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 2.4 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 2.1 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.1 | 0.9 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.1 | 1.0 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 1.5 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.1 | 1.5 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.1 | 0.1 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
0.1 | 3.7 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 2.3 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 0.3 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 1.0 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.1 | 0.4 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 0.1 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 2.1 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 0.5 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 0.2 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.1 | 0.3 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 1.3 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 2.2 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.1 | 1.9 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 0.2 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.1 | 1.0 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 1.2 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.1 | 0.2 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.1 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 1.1 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.1 | 0.2 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 1.2 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 0.1 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.1 | 0.2 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.1 | 0.9 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 0.6 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 1.5 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 1.3 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 0.1 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 0.3 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 0.2 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.1 | 2.1 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.1 | 0.3 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.1 | 1.3 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.1 | 0.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 0.3 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 0.2 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 0.9 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 1.1 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 3.8 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 1.2 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 3.4 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 2.4 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 0.7 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 0.8 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 0.7 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.1 | 1.4 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 1.2 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 0.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 0.6 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 0.2 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 0.8 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 0.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 0.2 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.1 | 0.2 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 0.1 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
0.1 | 0.4 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.1 | 0.8 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 2.3 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.1 | 0.4 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.5 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 0.0 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.0 | 0.7 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.1 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.0 | 1.2 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.0 | 0.7 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 1.1 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.0 | 3.3 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.5 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 1.4 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.9 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.2 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
0.0 | 1.5 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.5 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.9 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.0 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.0 | 0.2 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.0 | 2.7 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.0 | 0.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 0.0 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.3 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.0 | 0.7 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.0 | 0.8 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.2 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.3 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.5 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.6 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.6 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.3 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.0 | 0.4 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.4 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.5 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.0 | 0.5 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 1.5 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.0 | 0.6 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.4 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 0.7 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 1.6 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.0 | 1.6 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 4.1 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 1.3 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.6 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.4 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.4 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 1.9 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.4 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 0.5 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.0 | 0.2 | REACTOME ASSEMBLY OF THE PRE REPLICATIVE COMPLEX | Genes involved in Assembly of the pre-replicative complex |
0.0 | 0.3 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.0 | 0.5 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 1.1 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.0 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 0.4 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
0.0 | 0.3 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.1 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.0 | 0.3 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 0.3 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.0 | 0.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.0 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.0 | 0.4 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 0.1 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.0 | 0.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.2 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.4 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.0 | 0.4 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.0 | 0.0 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.0 | 0.0 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.0 | 0.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.1 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 0.1 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.0 | 0.1 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.0 | 0.1 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 0.0 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.0 | 0.2 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.8 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.4 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.0 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.3 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.2 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.0 | 0.3 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.0 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.0 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.0 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.0 | 0.1 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.3 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.1 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.2 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.0 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.0 | 0.6 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 0.0 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.0 | 0.1 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.0 | 0.1 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 3.5 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 0.0 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.1 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.1 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 0.4 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |